z-logo
open-access-imgOpen Access
Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load
Author(s) -
Calvin Q. Pan,
Zhongping Duan,
Erhei Dai,
Shuqin Zhang,
Guorong Han,
Yuming Wang,
Huaihong Zhang,
Huaibin Zou,
Baoshen Zhu,
Wenjing Zhao,
Hongxiu Jiang
Publication year - 2016
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1508660
Subject(s) - medicine , hbeag , hepatitis b virus , seroconversion , hepatitis b , pregnancy , transmission (telecommunications) , viral load , lamivudine , obstetrics , hbsag , immunology , virus , electrical engineering , engineering , biology , genetics
Few data are available regarding the use of tenofovir disoproxil fumarate (TDF) during pregnancy for the prevention of mother-to-child transmission of hepatitis B virus (HBV).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom